Water-Soluble 99% CAS 58186-27-9 Idebenone Powder Cosmetics Raw Material

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: >99%
• Purity: >99%
• Model NO.: TGY-8334
• Product Name: Idebenone
• Appearance: White Powder
• MW: 338.44
• Certificate: ISO 9001, USP
• Shelf Life: 24 Months
• Storage: Cool Dry Area
• Grade: Pharmaceutical Grade
• CAS No.: 58186-27-9
• Sample: Avaliable
• Service: OEM
• MOQ: 20g
• Assay: 99%Min, 99% HPLC
• Test Method: UV/HPLC
• Other Name: Idebenone Powder
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• Production Capacity: 3000kg/Month

Product Description

Product Name: Idebenone

CAS No.: 58186-27-9

Molecular Weight: 338.44

Appearance: orange powder

Molecular Formula: C19H30O5

Specification: 99%min

Idebenone is a structural relative of ubiquinone (Coenzyme Q10) that protects the CNS from the effects of ischemia via improving brain metabolism. It is reported to be of potential use in the management of patients with cerebral apoplexy, cerebral arteriosclerosis and related disorders.



Idebenone is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe. It is approved by the European Medicines Agency for use in Leber's hereditary optic neuropathy and was designated an orphan drug in 2007.